Martina Lubrano di Ricco linkedin.com/in/martina-lubrano-di-ricco ■ Career history: Business Development Manager, Prokarium Ltd, UK Business Development Analyst, Prokarium Ltd, UK PhD Candidate, INSERM, France ■ Education highlights: Executive MBA, Warwick Business School, UK PhD, Immunology, Sorbonne Université, France MSc, Medical, Molecular and Cellular Biotechnology, Università San Raffaele, Italy BS, Medical and Pharmaceutical Biotechnology, Università San Raffaele, Italy
Frederic Lutt linkedin.com/in/fredericlutt
■ Career history: Vice President of Client Success, MediaMath, UK Senior Head of Sales - Google Marketing Platform, Google, UK Head of Sales - DoubleClick, Google, UK Head of Account Management - Invite Media, Google, UK
■ Education highlights: Executive MBA, Warwick Business School, UK
MSc, e-Business Management, University of Warwick, UK BSc (Hons), International Business and IT, University of Teesside, UK BA equivalent, Business Techniques, University of Strasbourg, France
■ Nationality: French
■ Nationality: Italian
■ Languages:
■ Languages:
French (native) English (fluent) German (intermediate)
Italian (native) English (fluent) French (intermediate)
■ Career achievements: Successfully deployed the Invite Media offering across the EMEA region for Google. Sold the platform to many leading agencies across the EMEA region and helped them create their first programmatic trading desk. An example is the Audience On Demand trading desk of Publicis. Created the DoubleClick Partner Programme, which was scaled globally at Google. It is now known as the Google Marketing Platform Partners. Created and scaled several business units in the ad tech division of Google (DoubleClick). Created several sales and account management teams and generated several million dollars of incremental yearly revenue.
■ Career achievements: Successfully transferred academic experience and highly specialised immunology background into the private industry, supporting the growth of UK-based oncology biotech. Managed investment and partnering opportunities, identifying funding mechanisms and collaborations. Successfully raised US$21 million Series A in 2020 and setup a multi-year collaboration with a R&D group to grow the oncology pipeline. Developed and maintained an expert understanding of the scientific and asset landscape through competitive intelligence and market research: IP in-licensed in 2020 for lead programme.
Made with FlippingBook Learn more on our blog